These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20955350)

  • 1. Loss of Klotho during melanoma progression leads to increased filamin cleavage, increased Wnt5A expression, and enhanced melanoma cell motility.
    Camilli TC; Xu M; O'Connell MP; Chien B; Frank BP; Subaran S; Indig FE; Morin PJ; Hewitt SM; Weeraratna AT
    Pigment Cell Melanoma Res; 2011 Feb; 24(1):175-86. PubMed ID: 20955350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt5A activates the calpain-mediated cleavage of filamin A.
    O'Connell MP; Fiori JL; Baugher KM; Indig FE; French AD; Camilli TC; Frank BP; Earley R; Hoek KS; Hasskamp JH; Elias EG; Taub DD; Bernier M; Weeraratna AT
    J Invest Dermatol; 2009 Jul; 129(7):1782-9. PubMed ID: 19177143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparan sulfate proteoglycan modulation of Wnt5A signal transduction in metastatic melanoma cells.
    O'Connell MP; Fiori JL; Kershner EK; Frank BP; Indig FE; Taub DD; Hoek KS; Weeraratna AT
    J Biol Chem; 2009 Oct; 284(42):28704-12. PubMed ID: 19696445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma.
    O'Connell MP; Fiori JL; Xu M; Carter AD; Frank BP; Camilli TC; French AD; Dissanayake SK; Indig FE; Bernier M; Taub DD; Hewitt SM; Weeraratna AT
    Oncogene; 2010 Jan; 29(1):34-44. PubMed ID: 19802008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells.
    Ekström EJ; Bergenfelz C; von Bülow V; Serifler F; Carlemalm E; Jönsson G; Andersson T; Leandersson K
    Mol Cancer; 2014 Apr; 13():88. PubMed ID: 24766647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition.
    Dissanayake SK; Wade M; Johnson CE; O'Connell MP; Leotlela PD; French AD; Shah KV; Hewitt KJ; Rosenthal DT; Indig FE; Jiang Y; Nickoloff BJ; Taub DD; Trent JM; Moon RT; Bittner M; Weeraratna AT
    J Biol Chem; 2007 Jun; 282(23):17259-71. PubMed ID: 17426020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Age-Related Therapy Resistance in Melanoma by Rosiglitazone-Mediated Induction of Klotho.
    Behera R; Kaur A; Webster MR; Kim S; Ndoye A; Kugel CH; Alicea GM; Wang J; Ghosh K; Cheng P; Lisanti S; Marchbank K; Dang V; Levesque M; Dummer R; Xu X; Herlyn M; Aplin AE; Roesch A; Caino C; Altieri DC; Weeraratna AT
    Clin Cancer Res; 2017 Jun; 23(12):3181-3190. PubMed ID: 28232477
    [No Abstract]   [Full Text] [Related]  

  • 8. A t-butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasion.
    Jenei V; Sherwood V; Howlin J; Linnskog R; Säfholm A; Axelsson L; Andersson T
    Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19473-8. PubMed ID: 19901340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 drives melanoma cell motility through p38α-MAPK-dependent up-regulation of WNT5A expression.
    Linnskog R; Jönsson G; Axelsson L; Prasad CP; Andersson T
    Mol Oncol; 2014 Dec; 8(8):1365-78. PubMed ID: 24954857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor tyrosine kinase Ror2 mediates Wnt5a-induced polarized cell migration by activating c-Jun N-terminal kinase via actin-binding protein filamin A.
    Nomachi A; Nishita M; Inaba D; Enomoto M; Hamasaki M; Minami Y
    J Biol Chem; 2008 Oct; 283(41):27973-27981. PubMed ID: 18667433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation and loss of Secreted Frizzled-Related Protein 3 enhances melanoma cell migration and invasion.
    Ekström EJ; Sherwood V; Andersson T
    PLoS One; 2011 Apr; 6(4):e18674. PubMed ID: 21494614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WNT5A expression increases during melanoma progression and correlates with outcome.
    Da Forno PD; Pringle JH; Hutchinson P; Osborn J; Huang Q; Potter L; Hancox RA; Fletcher A; Saldanha GS
    Clin Cancer Res; 2008 Sep; 14(18):5825-32. PubMed ID: 18794093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of prostate cancer cell migration toward bone marrow stromal cell-conditioned medium by Wnt5a signaling.
    Jin F; Qu X; Fan Q; Wang L; Tang T; Hao Y; Dai K
    Mol Med Rep; 2013 Nov; 8(5):1486-92. PubMed ID: 24064566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenylmethimazole decreases Toll-like receptor 3 and noncanonical Wnt5a expression in pancreatic cancer and melanoma together with tumor cell growth and migration.
    Schwartz AL; Malgor R; Dickerson E; Weeraratna AT; Slominski A; Wortsman J; Harii N; Kohn AD; Moon RT; Schwartz FL; Goetz DJ; Kohn LD; McCall KD
    Clin Cancer Res; 2009 Jun; 15(12):4114-22. PubMed ID: 19470740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preparation of the recombinant lentiviral expression vector targeting human Wnt5a gene and its inhibitory effect on melanoma cell invasion].
    Zhao Y; Miao Y; Chen X; Wang L; Lu F; Liao W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):462-5. PubMed ID: 24796738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Filopodia formation mediated by receptor tyrosine kinase Ror2 is required for Wnt5a-induced cell migration.
    Nishita M; Yoo SK; Nomachi A; Kani S; Sougawa N; Ohta Y; Takada S; Kikuchi A; Minami Y
    J Cell Biol; 2006 Nov; 175(4):555-62. PubMed ID: 17101698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt5a suppresses colon cancer by inhibiting cell proliferation and epithelial-mesenchymal transition.
    Cheng R; Sun B; Liu Z; Zhao X; Qi L; Li Y; Gu Q
    J Cell Physiol; 2014 Dec; 229(12):1908-17. PubMed ID: 24464650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt5A regulates expression of tumor-associated antigens in melanoma via changes in signal transducers and activators of transcription 3 phosphorylation.
    Dissanayake SK; Olkhanud PB; O'Connell MP; Carter A; French AD; Camilli TC; Emeche CD; Hewitt KJ; Rosenthal DT; Leotlela PD; Wade MS; Yang SW; Brant L; Nickoloff BJ; Messina JL; Biragyn A; Hoek KS; Taub DD; Longo DL; Sondak VK; Hewitt SM; Weeraratna AT
    Cancer Res; 2008 Dec; 68(24):10205-14. PubMed ID: 19074888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assaying Wnt5A-mediated invasion in melanoma cells.
    O'Connell MP; French AD; Leotlela PD; Weeraratna AT
    Methods Mol Biol; 2008; 468():243-53. PubMed ID: 19099260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma.
    Weeraratna AT; Jiang Y; Hostetter G; Rosenblatt K; Duray P; Bittner M; Trent JM
    Cancer Cell; 2002 Apr; 1(3):279-88. PubMed ID: 12086864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.